Caryl and Israel Englander
Institute for Precision Medicine

You are here

what is precision medicine?

News

Latest news from The Englander Institute for Precision Medicine:

 

February 21, 2017
Entrepreneurship at Cornell (eLab) is a diverse, university-wide program that finds and fosters the entrepreneurial spirit in participants from every college, every field, and in every stage of life. Grounded in the belief that individuals who exhibit an entrepreneurial spirit and have acquired entrepreneurial knowledge can add significant value to any working environment from the smallest startup to the largest business, from non-profits to government agencies.
November 22, 2016

In a light-filled office, two young physician-scientists study how cancer forms, spreads, and recurs after remission. They meet once or twice a week where—amid leftover take-out containers and white-boarded walls—they write code, work through complex problems, and share recent triumphs and challenges.


November 1, 2016
Genomic testing is becoming an increasingly common starting place for the development of personalized medicine treatments for patients with a variety of hard-to-treat diseases, especially cancer, but organizations often struggle with interpreting and analyzing a glut of raw data produced by sequencing initiatives.
October 24, 2016
Basing decisions about cancer treatment on mutations and other somatic genomic abnormalities has become a standard of care for patients with some tumors types, but the use of targeted therapies rarely leads to cure, and responses can be incomplete. If clinical decisions are to improve, both mutation data and cell context—the cellular and genomic milieu in which the mutations are found—must be considered.
October 17, 2016
Chemotherapy is indicated as the first line of treatment for advanced bladder cancer. New research by Weill Cornell Medicine and University of Trento scientists shows that while chemotherapy kills the most common type of bladder cancer, urothelial cancer, chemotherapy also shapes the genetic evolution of remaining urothelial cancer cell clones to become drug-resistant.

Weill Cornell Medicine
Caryl and Israel Englander
Institute for Precision Medicine
413 E 69th Street
Belfer Research Building
New York, NY 10021 Phone: